Trial Profile
Pharmacodynamics of sugammadex in patients with neuromuscular blockade.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Aug 2014
Price :
$35
*
At a glance
- Drugs Sugammadex (Primary)
- Indications Neuromuscular blockade
- Focus Pharmacodynamics
- 13 Aug 2014 New trial record